Evidence map›Paper›PMID 31462137›Full record

ArticleActa oncologica (Stockholm, Sweden)2020

The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy.

Angelina Tjokrowidjaja, David Goldstein, H Malcolm Hudson, Sarah J Lord, Val Gebski, Stephen Clarke, Paul de Souza, Robert J Motzer, Chee Khoon Lee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta oncologica (Stockholm, Sweden), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study.International journal of urology : official journal of the Japanese Urological Association · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Angelina TjokrowidjajaNational Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Sydney, Australia.ORCID http://orcid.org/0000-0002-2020-2369
David GoldsteinTranslational Cancer Research Network, University of New South Wales, Sydney, Australia.ORCID http://orcid.org/0000-0001-6142-3291
H Malcolm HudsonNational Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Sydney, Australia.
Sarah J LordNational Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Sydney, Australia.ORCID http://orcid.org/0000-0003-2763-5949
Val GebskiNational Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Sydney, Australia.
Stephen ClarkeSydney Medical School, The University of Sydney, Sydney, Australia.
Paul de SouzaDepartment of Medical Oncology, Liverpool Hospital, Liverpool, Australia.ORCID http://orcid.org/0000-0002-7380-1170
Robert J MotzerDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-6925-2327
Chee Khoon LeeNational Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Sydney, Australia.ORCID http://orcid.org/0000-0003-2955-9820

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NomogramsAdolescentAdultAgedAged, 80 and overCarcinoma, Renal CellFemaleHumansKidney NeoplasmsLymphocytesMaleMiddle AgedNeutrophilsProtein Kinase InhibitorsRisk FactorsYoung AdultProtein Kinase Inhibitors

Identifiers

PMID31462137
PMCPMC7577380

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.